Ischemic Attack, Transient: Clinical Trials

2 trials for Ischemic Attack, Transient, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown. 2 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Unknown 2
Phase 31Unknown 1

Follow Ischemic Attack, Transient: new trials by email Literature Review of Ischemic Attack, Transient trials Research Report on Ischemic Attack, Transient

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
European Blood Pressure Intensive Control After Stroke
anti-hypertensive, home blood pressure measurement, telemonitoring and medication titration, Standard of Care Blood Pressure Management with Antihypertensives - Ischemic Stroke, Transient Ischemic Attack
Phase 2UnknownUniversity College Dublin1422024-05-022024-07-11
Evaluation of the STARFlex® Septal Closure System in Patients With a Stroke or TIA Due to the Possible Passage of a Clot of Unknown Origin Through a Patent Foramen Ovale (PFO)
STARFlex septal closure system, Best medical therapy - Patent Foramen Ovale, Stroke
Phase 2 / Phase 3UnknownNMT Medical9002003-06-012008-12-30

Narrower conditions

Foramen Ovale, Patent (1)  ·  Heart Septal Defects, Atrial (1)  ·  Hypertension (1)  ·  Ischemic Stroke (1)  ·  Myocardial Infarction (1)  ·  Recurrence (1)  ·  Stroke (1)

Broader conditions

Brain Diseases (2)  ·  Brain Ischemia (2)  ·  Cardiovascular Diseases (2)  ·  Central Nervous System Diseases (2)  ·  Cerebrovascular Disorders (2)  ·  Heart Diseases (2)  ·  Nervous System Diseases (2)  ·  Vascular Diseases (2)  ·  Cardiovascular Abnormalities (1)  ·  Congenital Abnormalities (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Disease Attributes (1)  ·  Heart Defects, Congenital (1)  ·  Heart Septal Defects (1)  ·  Infarction (1)

Interventions

Antihypertensive Agents (1)

Sponsors

NMT Medical (1)  ·  University College Dublin (1)

Countries

Ireland (1)  ·  United States (1)

Top investigators

Anthony Furlan, MD (1)  ·  Mark Reisman, MD (1)

Results publications

PMID 21051670, PMID 22417252, PMID 25147037, PMID 36398903